Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01213602
Other study ID # SAB-ANE-2010-01
Secondary ID
Status Completed
Phase N/A
First received October 1, 2010
Last updated July 22, 2011
Start date February 2010
Est. completion date February 2011

Study information

Verified date February 2011
Source Hospital Universitari de Bellvitge
Contact n/a
Is FDA regulated No
Health authority Spain: Spanish Agency of Medicines
Study type Observational

Clinical Trial Summary

The principal objective is to notice the relevance of timing performance of femoral block for knee replacement surgery during general anesthesia and analyze the relationship with bilateral bispectral index (BIS) monitoring during induction and maintenance of anesthesia. Otherwise the investigators try to investigate if the timing of performance of this block influence in postoperative variables as pain or blood loss.


Recruitment information / eligibility

Status Completed
Enrollment 85
Est. completion date February 2011
Est. primary completion date February 2011
Accepts healthy volunteers No
Gender Both
Age group 50 Years to 90 Years
Eligibility Inclusion Criteria:

Exclusion Criteria:

ASA IV, patients with difficult airway management, patients with antecedent of cerebral ischemia, presence of atrioventricular fistula, patients with absent distal pulses or history of vascular surgery in the involved limbs, patients with high risk of deep vein thrombosis.-

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
Spain Antoni Sabate Pes Hospitalet de Llobregat Barcelona

Sponsors (1)

Lead Sponsor Collaborator
Hospital Universitari de Bellvitge

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Sevoflurane requirements Combined ( femoral block and general anesthesia) or balanced anesthesia ( intravenous analgesics and general anesthesia) is evaluated on the requirements of inhalational hypnotics during surgery. Schedule time when BIS has to be in proper range (40-60): T1 T2 T3 T4 T5 T6
T1 Induction T2 Inflated cuff ischemia T3 Incision T4 Unlocking cuff ischemia T5 End surgery T6 Time to wake the patient from the close of the sevoflurane vaporizer
Each time include a period of adjustment in 5 minutes
6 months Yes
Secondary Intraoperative and postoperative opiates requirements and relations with CVI Time surgery and 24,48 and 72 h postoperative Yes
See also
  Status Clinical Trial Phase
Completed NCT01410240 - Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty Phase 4
Not yet recruiting NCT06382285 - The Effect of a Prolonged Peripheral Nerve Block on the Level of Pain After a Knee Replacement N/A
Recruiting NCT05950646 - Mini-dose Dexmedetomidine-Esketamine Infusion and Perioperative Sleep Quality Phase 4
Not yet recruiting NCT05246007 - Nocturnal Low-dose Dexmedetomidine Infusion and Perioperative Sleep Quality N/A
Recruiting NCT06234631 - Cannabidiol for Postoperative Opioid Reduction in Primary Total Knee Arthroplasty Phase 2
Completed NCT01375231 - Anatomic Reconstruction of the Patellofemoral Joint Phase 4
Completed NCT01622647 - The Effect of Nasal Continuous Positive Airway Pressure (N-CPAP) on Arterial pCO2 During Spinal Anesthesia N/A